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Abstract
Background: Viruses are incredibly diverse organisms and impact all forms of life on Earth; however, individual
virions are challenging to study due to their small size and mass, precluding almost all direct imaging or molecular
analysis. Moreover, like microbes, the overwhelming majority of viruses cannot be cultured, impeding isolation,
replication, and study of interesting new species. Here, we introduce PCR-activated virus sorting, a method to
isolate specific viruses from a heterogeneous population. Specific sorting opens new avenues in the study of
uncultivable viruses, including recovering the full genomes of viruses based on genetic fragments in metagenomes,
or identifying the hosts of viruses.
Methods: PAVS enables specific sorting of viruses with flow cytometry. A sample containing a virus population is
processed through a microfluidic device to encapsulate it into droplets, such that the droplets contain different
viruses from the sample. TaqMan PCR reagents are also included targeting specific virus species such that, upon
thermal cycling, droplets containing the species become fluorescent. The target viruses are then recovered via
droplet sorting. The recovered virus genomes can then be analyzed with qPCR and next generation sequencing.
Results and Conclusions: We describe the PAVS workflow and demonstrate its specificity for identifying target
viruses in a heterogeneous population. In addition, we demonstrate recovery of the target viruses via droplet
sorting and analysis of their nucleic acids with qPCR.
Keywords: Droplet microfluidics, Next generation sequencing, Single virus genomics

Introduction
Viruses impact every form of life on earth, from applying
evolutionary stresses to enhancing the transfer of genes
between organisms [1–4]. Many human diseases are
caused by viruses, including acute diseases like Ebola [5]
and influenza [6], and chronic diseases caused by
Epstein-Barr Virus (EBV) [7], Human Immunodeficiency
Virus (HIV) [8], and Zika virus [9]. Studying viruses is
thus important to human health, but also for elucidating
the incredible mechanisms they’ve evolved to survive,
replicate, and spread; these discoveries may lead to new
molecular techniques and methods for treating disease.
* Correspondence: adam@abatelab.org
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Francisco, San Francisco, California, USA
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Studying viruses, however, can be challenging. They are
usually much smaller than the diffraction limit of light
and thus not directly visible with optical microscopy. They
contain miniscule amounts of nucleic acid and protein,
making direct sequencing or proteomic characterization
of individual virus particles challenging [10]. To overcome
these issues, the standard strategy is to culture the virus of
interest to produce sufficient quantities for biological
assays, such as gel electrophoresis, infection assays, or
visualization with super-resolution or electron microscopy. However, like microbes, most viruses cannot be
cultured [11], as this requires knowledge of which host
cells the virus replicates in which, for most viruses, are
also likely uncultivable [12, 13].
When a virus cannot be cultured, molecular methods
are valuable. For example, viruses can be purified from a
sample using filtration, flocculation, or density-dependent
centrifugation, to recover particles of the appropriate size
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range, and the nucleic acids purified for PCR or next
generation sequencing [14, 15]. This can be applied
directly to environmental viruses and provides a genetic
snapshot of organisms in that environment, and has
yielded numerous insights into virus phylogeny and
fundamental biology [14, 15]. However, viruses are also
the most diverse organisms on the planet and viral
samples often comprise sequences from trillions of
entities, exceeding by orders of magnitude the limits of
modern sequencers to sequence them [16]. As a result,
such “shotgun” sequencing provides a sparse sampling of
the system recovered as billions of short, hundred-base
reads [17]. To extract meaningful biological insight from
this complex data, the reads must be pieced into viral
genomes, introducing substantial bioinformatic challenges
that, often, cannot be overcome [10, 18, 19]. Most often,
only genomic sequences for the most abundant organisms
can be completely recovered and relatively little is learned
about the vast number of new viruses present at low-tomoderate levels [20, 21]. To enhance the investigation of
viral ecosystems, a method for culture-free purification of
specific species would be valuable; however, as of yet, no
method exists for specific sorting of viruses.
In this paper, we present specific and high throughput
sorting of viruses, PCR-Activated Virus Sorting (PAVS).
Using microfluidics, we encapsulate single particles from
a population of diverse viruses into monodisperse double
emulsion droplets. PCR reagents targeting specific
genetic loci are also included, interrogating every droplet
for these sequences. If a particle contains them, PCR signals are generated that cause the droplet to become
fluorescent, making it sortable by double emulsion flow
cytometry [22]. The recovered droplets can be ruptured
and the material subjected to additional analyses, such
as quantitative PCR or digital PCR and sequencing. The
approach is simpler than antibody-based labeling and
sorting of cells [23] because designing PCR TaqMan
assays for specific detection of sequences is much easier
than generating high affinity antibodies with which to
label and sort single virus particles by flow cytometry.
Moreover, the implementation of TaqMan PCR allows
multiplexing to interrogate each virus for distinct
sequences. Additionally, the use of TaqMan assays can
be designed to incorporate “degenerate” sequences [24],
allowing for the identification and recovery of diverse
viral genomes. As we show, multiplexing can be used to
measure the length distributions of viral genomes in a
sample and is extendable to sequences that are not physically connected, such as genomic segments of viruses
like influenza, or the 16S ribosomal RNA (rRNA)
sequence of a bacterial cell harboring the target virus.
Flow cytometric sorting has become a universal tool in
cell biology and microbiology and PAVS allows it to be
applied to viruses for the first time.
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Methods
Preparation of viral samples

Bacteriophage T4 (T4) and bacteriophage ФX174
(ФX174) were obtained from Carolina Biological Supply.
T4 is propagated by infection of Escherichia coli (E.coli)
B (ATCC 11303) and ФX174 by infection of E.coli C
(ATCC 13706). Bacteriophage lambda cI857ts is obtained from the lambda lysogen E.coli strain KL470 and
propagated by infection of E.coli C600. Viral particles
are collected from the supernate of the cultures and
stored at 4 °C until experimentation. Initial viral stock
concentrations are: T4 1×1012 pfu/mL, ФX174 1×1010
pfu/mL, Lambda 5×109 pfu/mL.
Microfabrication of devices

The microfluidic devices are fabricated using soft lithography in poly(dimethylsiloxane) (PDMS) [25]. SU-8 masters are fabricated by photolithography and used to
mold PDMS devices by mixing PDMS polymer and
cross-linker at a ratio of 11:1, pouring over the master,
degassing to remove air bubbles, and baking at 75oC for
4 h to solidify. The device is extracted from the master
with a scalpel, and inlet and outlet ports added with a
0.75 mm biopsy punch (Harris, Unicore). The device is
washed with isopropyl alcohol and patted with Scotch®
tape to remove debris prior to plasma bonding. The flow
focus drop maker is bonded to a glass slide, baked at
75oC for 15 min, and treated with Aquapel to render the
channels hydrophobic for water-in-oil emulsification.
The double emulsion device is bonded and baked at
75oC for 48 h to completely revert the wettability to its
native hydrophobic state. To pattern the channel wettability for double emulsification, select ports are blocked
with Scotch tape, leaving others open for oxygen plasma
treatment of 1 min [26].
Encapsulation, PCR, and identification of viruses in single
emulsions

To make single emulsions for viral detection, quantification, and genome length determination, the samples are
first diluted in phosphate buffered saline and mixed with
PCR reagents (Platinum Multiplex PCR Master Mix,
Thermo Fisher) and PCR primers and TaqMan probes
(Integrated DNA Technologies; IDT) specific for the
species of interest. For detection or quantification, T4
viral particles are first diluted from the stock sample to
ranges of 1×106-5×108 virus per sample prior to mixing
with PCR reagent. For ApaI restriction enzyme digestion
(NEB) or Fragmentase digest (New England Biolabs;
NEB), Lambda DNA is treated enzymatically prior to the
mixing with the PCR reagents. The oil phase of the
emulsion consists of HFE-7500 fluorinated oil (3M) with
2% (w/w) PEG-PFPE amphiphilic block copolymer
surfactant [27]. These solutions are loaded into syringes
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(BD 1 mL luer lock; 27G ½” needle), and the virus and
PCR solution into a syringe atop 200 μL HFE-7500 oil;
the oil acts as a hydraulic to push the solution into the
device to accommodate for dead volumes, allowing
nearly all of the solution to be used. The syringes are
mounted onto pumps (New Era) with needles (BD),
polyethylene tubing (PE-2) is affixed to the needles, and
the syringes are primed by flowing at 5,000 μL/h prior
to connecting them to the device. Flow rates are controlled with a custom Python script and set to 300 μL/h
for the virus sample and 700 μL/h for the oil. The single
emulsion droplets exit the device through PE-2 tubing
and are collected into a 1.5 mL microcentrifuge tube.
Single emulsions produced by this method are ~20 μm
in diameter and monodispersed.
To prepare the single emulsion droplets for thermal
cycling, the sample is transferred from the 1.5 mL
microcentrifuge tube into 0.2 mL PCR tubes. The HFE7500 oil is removed using a needle and is replaced with
FC40-fluorinated oil with 5% Polyethylene glycolperfluoropolyether (PEG-PFPE) amphiphilic block
copolymer surfactant. The sample is cycled on a T100
thermal cycler (Bio-Rad) according to the Platinum
Multiplex Master Mix instructions. After thermocycling,
subsamples of single emulsions are subjected to
visualization using a 6D High Throughput microscope
(Nikon) with a 10× objective. Bright field, Cyanine 5
(Cy5) and fluorescein (FITC or FAM) images are
acquired for every field of view. After image acquisition,
ImageJ (National Institute of Health; NIH) is used to
identify droplets based on their circular boundaries in
the bright field images and then measure their fluorescence in the Cy5 and FITC images. The fraction of positive droplets is determined by counting the number with
fluorescence signal above a threshold value, divided by
the total number of imaged droplets. Samples are tested
in triplicate and comprise a minimum of 5000 droplets.
Encapsulation, PCR, and enrichment of viruses in double
emulsion droplets

To make double emulsions, the virus samples are first
diluted in phosphate buffered saline. Approximately 1200
T4 virions are mixed with 1.4×105 ФX174 before combining with PCR reagents (Platinum Multiplex PCR Master
Mix, Thermo Fisher) and PCR primers (IDT) specific for
the species of interest. The middle phase of the double
emulsion consists of HFE-7500 fluorinated oil (3M) with
2% (w/w) PEG-PFPE amphiphilic block copolymer surfactant [27], and the carrier aqueous phase of 4% (v/v) Tween
20, 1% (v/v) Pluronic F-68 (Gibco), and 10% (w/v) PEG
(molecular weight 35 K) in water [26]. These solutions are
loaded into syringes and processed through a microfluidic
double emulsion maker using syringe pumps, similar to the
single emulsions. The flow rates are 90 μL/h for the virus
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sample, 80 μL/h for the oil, and 250 μL/h for the outer
aqueous phase. The double emulsion droplets exit the
device through PE-2 tubing and are collected into a 1.5 mL
microcentrifuge tube. Double emulsions produced by this
method are ~35 μm in diameter and monodispersed.
To prepare the double emulsion droplets for thermal
cycling, the sample is transferred from the 1.5 mL
microcentrifuge tube into 0.2 mL PCR tubes, such that
each contains 90 μL of emulsion and 10 μL of fresh PCR
buffer; the PCR buffer consists of 30 μL of 50 mM
MgCl2 and 100 μL of 200 mM Tris pH 8.0 and 500 mM
KCl and is essential for preventing PCR components
from leaching out of the droplets into the carrier phase,
in which they are soluble. The sample is cycled on a
T100 thermal cycler (Bio-Rad) according to the Platinum Multiplex Master Mix instructions. After thermal
cycling, 1× SYBR Green I (Life Technologies) is loaded
into the carrier phase, permeating through the double
emulsion shell and staining the droplets that have undergone PCR amplification.
A fluorescence-activated cell sorter (FACS) Aria II
(BD) is used to sort the emulsions to recover droplets
that contain the virus of interest. The FACS chamber
temperature is set to 4°C and agitation speed to the
highest setting to prevent droplets from sedimenting
during the sort. The droplets strongly scatter the FACS
laser, requiring a 2× Neutral Density (ND) filter to
decrease signal into the detectable range. The microfluidic device produces uniform double emulsions and,
consequently, the droplets appear as a compact cluster
in forward versus side scatter, making them easy to distinguish from particulate and small oil droplets, which
the FACS is instructed to ignore.
The sample is analyzed in batches by diluting 100 μL of
emulsion into 200 μL of 2% (v/v) Pluronic F-68 and 1% (w/
v) PEG (molecular weight 35 K) in water, and gently mixing
using a 200 μL pipette tip. The sample is loaded into the
FACS and the double emulsions gated in the Forward Scatter (FSC) and Side Scatter (SSC) channels [22]. To read the
SYBR channel relating to amplification, we use a 488 nm
laser and a 505LP optical filter (BD Biosciences); the population has two peaks, one with low average intensity representing empty or negative droplets, and another with high
average intensity representing SYBR positive droplets,
which we gate to recover in either Eppendorf tubes (bulk
recovery of target virus from a mixed population) or 96well plates (recovery of single virion from a mixed sample).
We use the strict “purity” setting of the instrument which
discards events in which multiple droplets pass through the
detection window at the same time.
Amplification of recovered viral DNA

Sorted droplets are briefly centrifuged to the bottom of
the tube. To release nucleic acids, the droplets are
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ruptured by adding 20 μL of DI water and 50 μL of
perfluoro-1-octanol (PFO), and vortexing for 1 min. The
sample is centrifuged again, and the aqueous top phase
containing the viral DNA removed using a micropipette.
To confirm enrichment of T4 phage in the sorted
emulsion, we use quantitative PCR (qPCR). The concentration of viral DNA is too low post-sorting to be reliably detected by bulk qPCR. To address this, we nonspecifically amplify the material using digital droplet
multiple displacement amplification (ddMDA) prior to
qPCR analysis using the Qiagen REPLI-g Single Cell Kit.
ddMDA is a non-specific method that amplifies all nucleic acids in a sample uniformly [28]. The sample is incubated with 3 μL of the Denaturation Solution for 10
min at 65°C. After heating, the reaction is halted by adding 3 μL of Stop Solution Mix. 20 μL of the REPLI-g sc
Master Mix containing 14.5 μL of REPLI-g sc Reaction
Buffer, 4.5 μL of water, and 1 μL of REPLI-g sc Polymerase is added to each sample. The sample is encapsulated
into droplets using a 20 μm flow-focus drop maker [29,
30] and HFE-7500 fluorinated oil with 2% (w/w) PEGPFPE amphiphilic block copolymer surfactant. The
emulsion is collected into a 1.5 mL microcentrifuge tube
and the reaction incubated at 30°C for 16 h. After incubation, the droplets are ruptured by adding 10 μL of
PFO, vortexing, and spinning as above.
Quantitative PCR analysis of sorted droplets

To confirm that PAVS enriches for bacteriophage T4
over bacteriophage ФX174, we estimate concentrations
of both viruses in the sorted and unsorted pools using
qPCR (Stratagene Mx3005P, Agilent). The qPCR primer
sequences are different from the ones for PAVS detection, so that in-droplet amplification products do not
skew qPCR results. Cross-threshold (Ct) values for T4
and ФX174 in pre- and post-sorted samples are used to
compute an enrichment factor. The amplification reagent for all the qPCR measurements is Maxima SYBR
Green Master Mix (Thermo Scientific), and the qPCR
primers are listed in Additional file 1: Table S1.

Results
PAVS enriches for specific viral species from a
heterogeneous sample

PCR-Activated Virus Sorting allows specific viruses in a
mixed population to be detected and recovered by sorting. This is accomplished by encapsulating the viruses in
double emulsion droplets using microfluidic technology
and performing PCR in each droplet to probe for
sequences of interest. Because the viruses are encapsulated at 0.1 per droplet, most droplets are empty or contain a single virion, in accordance with Poisson statistics
(Fig. 1). If the target virus is present in a droplet, PCR
amplification occurs, generating a fluorescent signal that
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Fig. 1 PCR-Activated Virus Sorting (PAVS) workflow. Virus
suspensions are encapsulated with PCR reagent and probe in
double emulsion droplets, then thermal cycled and stained with
SYBR Green. FACS recovers fluorescent droplets containing the viral
species of interest, generating an enriched sample that is ready for
downstream processing

can be detected and recovered by FACS. Due to the
rapid rate at which microfluidics can encapsulate
individual virions in droplets (>1 KHz), millions of single
virus particles can be sorted in a few hours.
Specific detection and quantification of viral genomes

To identify a virus in a droplet, PAVS uses a PCR assay
interrogating for sequences that exist within the target
species. In this way, the PCR primers are analogous to
antibodies when sorting cells with FACS, providing a
detectable fluorescence signal only when the target species is present. However, whereas generating high affinity
antibodies against a target virus can be challenging,
especially if it is uncultivable, designing specific PCR
primers is straightforward. This makes PAVS general,
allowing it to recover any virus of interest to which PCR
primers can be designed. To illustrate this, we perform
digital TaqMan PCR on samples containing T4, ФX174,
and lambda virus, using probes specific for only bacteriophage T4 (Additional file 1: Table S1). The droplets
are visualized using epifluorescence imaging after thermal cycling. As expected we observe TaqMan positive
droplets in the T4 sample, demonstrating successful
amplification when this virus is present (Fig. 2a). By contrast, TaqMan fluorescence is absent in the ФX174 and
lambda negative controls (Fig. 2a), confirming that the
reaction is specific. This shows that our TaqMan PCR
assay can be used to differentiate between single virus
particles of these species.
In addition to enabling the detection of specific viruses
in a sample, PAVS can count individual virus particles.
To demonstrate this, we analyze a dilution series of T4
bacteriophage, reading out the results with fluorescence
microscopy and image analysis. We find that, as expected, the fraction of positive droplets is directly proportional to T4 concentration (Fig. 2b). This is due to
the viruses being loaded at limiting dilution, such that
most droplets are empty but a small fraction contain
virus particles. Under such conditions, the viruses are
encapsulated individually and the number of droplets
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a

b

Fig. 2 a T4, ФX174, and lambda virions are partitioned into droplets with TaqMan primers and probe specific for T4. After thermal cycling, the T4
sample has TaqMan signal while the ФX174 and lambda negative controls have no signal, demonstrating that digital droplet PCR specifically
detects target viruses. b The fraction of TaqMan positive droplets in digital PCR for T4 is closely related to the input T4 concentration, showing
that digital droplet PCR quantitatively measures viral concentration. Error bars indicate the standard deviation for triplicate measurements

containing a virus is approximately equal to the number
of viruses in the sample, in accordance with random
Poisson encapsulation. As with qPCR, the minimum
number of viruses necessary for PAVS depends on the
specificity of the TaqMan assay. A strength of TaqMan
assays is that they are highly specific, allowing confident
detection of rare virus species. For example, in initial
tests of this approach, we found that the rate of nonspecific amplification in a droplet is 1 in ~100,000, so
that viruses less rare than this can be confidently detected. Since we can routinely sort >2 million droplets in
a single FACS run, this allows us to detect as few as ~20
virus particles in a sample.
Multiplexed digital PCR can detect full-length virus
genomes

A unique and valuable property of PAVS is that it can
differentiate between viruses that contain just one target sequence and others that contain multiple. This is
possible because TaqMan PCR can be multiplexed
using probes targeting different sequences labeled with
fluorescent dyes of different color. Hence, viruses containing one sequence will be positive only at one color,
whereas those with two sequences will be positive for

two colors. These populations can then be separated by
gating the fluorescence measurements to recover single- or double-positive droplets. To demonstrate the
ability to multiplex the reaction, we synthesize primers
and Cy5 TaqMan probes targeting a genomic region
near the 5’ end of the lambda genome, and others targeting regions at increasing distances away from the 5’
end. The primer and probe sequences are listed in Additional file 1: Table S1, and a graphical representation of
the probe locations with the Cy5 TaqMan probe in red
and the FAM TaqMan probes in green is provided in
Fig. 3a. Lambda DNA is combined with the PCR reagents and the sample is emulsified using the microfluidic device. After thermal cycling, the droplets are
imaged using fluorescence microscopy (Fig. 3b) and analyzed to measure their intensity on the Cy5 and FAM
channels (Fig. 3c). The droplets are characterized as
positive for both targets (Cy5+FAM+), positive for one
target (FAM + Cy5-, FAM−Cy5+), or negative for both
(FAM−Cy5−). Each multiplexed PCR is performed in
triplicate, containing 5000–8000 droplets.
We observe less multiplexing when probe pairs are far
apart, indicating that the probability that two target
sequences exist within a given genome decreases for

Lance et al. Virology Journal (2016) 13:201

Page 6 of 9

a
b

d

c

Fig. 3 a Location of TaqMan PCR Cy5 probe in the lambda genome is shown in red, FAM probes are shown in green, and the location of the
ApaI restriction site is shown in black. b Representative image of multiplexed PCR emulsion on Lambda DNA. c Representative scatterplot of Cy5
and FAM intensities for Lambda DNA. d Fraction of multiplexed droplets for Lambda DNA undigested (blue), ApaI digested (red), and
Fragmentase digested (green)

sequences that are more separated (Fig. 3d, blue curve); this
implies that the genomes might be partially fragmented. To
investigate this further, we perform a negative control in
which we digest the genome with a restriction endonuclease cleaving at position 10,086 base pairs (bp), which is
between the first and second FAM probes. If fragmentation
is the source of lowered multiplexing signal, then the fraction of double-positives should fall precipitously beyond the
cleavage point; indeed, this is what we observe, as shown by
the red curve in Fig. 3d. As an additional negative control,
we digest the lambda genome using a non-specific endonuclease (Fragmentase) producing ~500 bp products, and
observe that double-positives are rare for all probe pairs
(green curve). This demonstrates that PAVS can
characterize the length distributions of viral genomes in a
solution and, more generally, the presence of multiple genetic loci in a target virus; this should be useful for studying
correlations between loci in single viruses that are on the
same linear molecule or on entirely different molecules,
such as in segmented virus genomes. PAVS can also be
used to characterize the integrity of viral genomes.
PAVS allows target virus to be sorted out of a mixed
population

The PAVS workflow consists of two steps, a first in
which target viruses are detected using single virus PCR
in droplets, and a second in which the droplets are
sorted to recover the target viruses. To demonstrate this,
we construct a mixed sample of two bacteriophages, T4
and фX174, at a ratio of 1:999 respectively. This 0.1% T4
spike-in is encapsulated at limiting dilution in droplets
with PCR primers specific for T4 phage, thermally

cycled, and stained with SYBR Green. If a particular
droplet contains T4, the nucleic acids targeted by the
PCR primers are amplified and the SYBR stain produces
a fluorescent signal that fills the droplet. The fluorescence signal is detected with FACS and the positive
droplets sorted into a 1.5 mL microcentrifuge tube.
To validate that the PAVS workflow enriches for T4 over
ФX174, we quantify virus concentrations in the sorted and
unsorted pools using qPCR. The sorted droplets are ruptured and the viral genomes amplified by ddMDA. Equal
concentrations of T4 and ФX174 DNA from the unsorted
and sorted emulsions are subjected to qPCR (Fig. 4). The
primers used to detect T4 target a different locus than the
ones for PAVS sorting (Additional file 1: Table S1). The
qPCR curve for T4 shifts to lower cycles post-sorting, demonstrating that T4 has been enriched. By contrast, the
curve shifts to higher cycle numbers for ФX174, indicating
that this virus has been de-enriched by sorting, as expected.
To quantify the degree of enrichment, we compute an enrichment factor e defined as,


ðn þ 1Þ ΔC1tT4

2
;
e¼ 
1
1
þ
n
ΔC T4
ΔC фX174
t
t
2

2

where n is the ratio of the viral species with respect to
and ΔCфX174
are the differences
one another and ΔCT4
t
t
of cross-threshold values for T4 and фX174, respectively.
For this experiment, n = 999, ΔCT4
is 2.16, and ΔCфX174
t
t
is 5.45, yielding e = 9.69, indicating that the final sample is
enriched by about tenfold for T4 from an initial concentration of 0.1%. The degree of enrichment is tunable over a
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Fig. 4 qPCR detection of bacteriophages фX174 and T4 before and
after FACS sorting. The shifts in the curves reflect the 2-fold change
of the DNA quantity according to the specific primers being tested.
Samples tested in triplicate

large range, as the rarer the target is in the droplets before
sorting, the more it is enriched thereafter. Conversely, if the
target is abundant, then many droplets will be positive and
only a minor enrichment is possible. To increase enrichment, the sample is thus diluted prior to partitioning in
droplets, which reduces the rate of co-encapsulation of
different viruses and false-positive recovery of off-target
species. The enrichment possible is also limited by the
false-positive rate of droplet detection, which sets an upper
bound to how much the sample can be diluted. The falsepositive rate for our TaqMan assay is ~1/100,000 droplets,
setting a theoretical upper enrichment limit of ~100,000×;
however, the maximum enrichment achieved in practice
can also be limited by other considerations, such as a the
specificity of assays or the number of positive viruses that
must be recovered for downstream characterization.
PAVS recovery of single virions from a mixed sample

Common FACS instruments can pool all positive droplets into one well or dispense controlled numbers into
different wells, including down to single droplets. This is
commonly used to isolate cells for single cell analysis
(Fig. 5a). When combined with PAVS, this allows a
heterogeneous mixture of viruses to be sorted, to isolate
specific virions in the sample, which can then be subjected to additional analyses, such as qPCR. To illustrate
this, we sort a sample of lambda virus with PAVS and
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dispense the positive droplets into wells in controlled
numbers (Additional file 1: Table S1, Lambda FWD 2,
Lambda REV 2, and Lambda probe 2). We load 1, 10, or
50 positive droplets into each well and analyze the recovered material with qPCR for primers targeting a different portion of the lambda genome than was amplified
in the PAVS detection (Additional file 1: Table S1). The
Ct values decrease as the number of viruses dispensed
increases, indicating that the viruses are present at
higher numbers (Fig. 5b). When fewer than 50 viruses
are sorted, it is difficult to reliably detect them in the
sorted wells; wells with 10 viruses show amplification at
Ct values of 33, while single viruses do not amplify above
the negative controls.
To confirm that the sorting is specific, we generate
qPCR curves for wells containing 50 positive droplets and
wells containing 50 unsorted droplets. The qPCR curve
shifts left by an average of 4.24 Ct values, demonstrating
that the Lambda virus is more abundant in the sorted
sample (Fig. 5c). While our results show that single viruses
provide too little DNA for detection with standard qPCR,
other post-sorting amplification methods could be implemented to improve sensitivity, such as higher efficiency
PCR reagents, nested PCR [31], or non-specific ddMDA
followed by qPCR [28]. Because DNA can fragment under
flow through narrow channels, the ability to perform
multiplexed TaqMan assays in the droplets can be used to
identify and dispense only intact viral genomes into the
wells.

Discussion and conclusions
PCR-activated virus sorting enables specific detection
and isolation of target viruses from a mixed sample,
analogous to what is possible with FACS for cells. PAVS
has significant advantages over conventional approaches
to virus genome study. For example, just as when studying microbes, specific and high throughput virus sorting
should be valuable whenever large populations must be
analyzed to recover a target species; this requires that
only ~ 100 bp of the virus’s genome be known with
which to generate identifying TaqMan probes. For a
presently-unknown species, this information may be obtained by performing short-read shotgun sequencing on
a sample, or consulting existing metagenomic databases.
PAVS can detect viruses residing within host microbes,
including bacteria and eukaryotic cells. This is accomplished through the encapsulation of host cells followed by
lysis, and subjection to TaqMan PCR for virus detection,
which produces a positive signal if the virus is present
within the host. The sorted hosts can then be subjected to
SSU rRNA profiling or next generation sequencing to identify the species. This capability should be valuable for
characterizing virus-host relationships in microbial ecologies or the human microbiome, for example, to determine

Lance et al. Virology Journal (2016) 13:201

a

Page 8 of 9

b

c

Fig. 5 a Workflow schematic for targeted virus sorting into well plates using PAVS. b qPCR detection of Lambda for 1, 10, or 50 viruses sorted
into a well. Positive control of Lambda DNA shown in inset. c qPCR curves for 50 sorted or unsorted Lambda viruses per well. Positive control of
Lambda DNA shown in inset. Samples tested in duplicate

which viruses infect which hosts – something that is
presently extremely challenging due to the inability to
culture most viruses and host microbes.
PAVS opens new avenues in the study of virus-mediated
disease, such as HIV and EBV, where it enables detection
of viral infection within host cells. Unlike oligonucleotide
staining, PAVS reliably detects single molecule viral
genomes of interest. Moreover, the cells that are positive
for infection can be recovered by sorting, allowing their
genomes and transcriptomes to be sequenced. For
example, the recovered cell lysates can be sequenced to
characterize insertion sites of the virus, epigenetic correlations with virus infection, identify genome mutations of
the specific virus of interest, or modulation of host cell
transcriptome. This will be valuable for studying the basic
biology of the virus and to better understand how it survives, replicates, and evades the host immune response.
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